2025年杜普伊特伦挛缩症全球市场报告

预计未来几年杜普伊特伦挛缩症的市场规模将出现强劲成长。预计到 2029 年将成长至 57.6 亿美元，年复合成长率（CAGR）为 6.0%。预测期内的预期成长归因于治疗方案的进步、认识的提高和早期诊断、医疗保健支出的增加、微创手术的采用率的提高以及研发活动的扩大等因素。这段时期的主要趋势包括基因治疗的突破、再生医学和干细胞疗法的进步、人工智慧诊断工具的创新、客製化矫正器具的 3D 列印的进步以及微创手术技术的持续发展。

微创治疗的日益普及预计将推动杜普伊特伦挛缩症市场的成长。这些治疗只需极少的切口和组织损伤，从而减少疼痛和疤痕。越来越多的患者选择微创手术，因为与传统手术相比，微创手术恢復更快、不适感更少、併发症风险更低。这些治疗方法可以有效地帮助杜普伊特伦挛缩症患者恢復手部功能、减少挛缩并确保更快、更舒适的復健。例如，澳洲皇家外科医学院（RACS）2023年6月的报告发现，在澳洲使用达文西平台的手术增加了12%，从2021年的17,852例增加到2022年的19,989例。因此，微创治疗的使用增加是推动杜普伊特伦挛缩症市场扩张的主要因素。

杜普伊特伦挛缩症市场的主要企业正专注于临床试验，以开发新型的第一线缓解疾病治疗方法。进行临床试验是为了评估新治疗方法、新药或新程序的安全性、有效性和潜在副作用。 2023 年 4 月，Ventoux Biosciences（美国）宣布针对杜普伊特伦挛缩的纤维化治疗的临床前试验取得了积极成果，该疾病影响了约 5% 的美国人口。该公司的主要候选药物 VEN-201 是一种重新利用的市售药物，已证明可有效抑制小鼠模型中的皮肤纤维化。鑑于这些令人鼓舞的结果，Ventoux 已启动一轮资金筹措以支持 VEN-201 的开发。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 - 市场 - 宏观经济情境 宏观经济情境包括利率、通膨、地缘政治以及感染疾病和復苏对市场的影响

第五章 全球成长分析与策略分析框架

• 全球杜普伊特伦挛缩症市场 PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素、限制因素）
• 最终用途产业分析
• 全球杜普伊特伦挛缩症市场：成长率分析
• 全球杜普伊特伦挛缩症市场表现：规模与成长，2019-2024 年
• 全球杜普伊特伦挛缩症市场预测：2024-2029 年及 2034 年规模与成长
• 全球杜普伊特伦挛缩症总目标市场（TAM）

第六章市场区隔

• 全球杜普伊特伦挛缩症市场（按疾病类型、表现和预测），2019-2024 年、2024-2029 年、2034 年
• I型
• II型
• III型
• 全球杜普伊特伦挛缩症市场（按治疗、表现和预测），2019-2024 年、2024-2029 年、2034 年
• 外科手术
• 放射治疗
• 针腱膜切开术
• 类固醇注射
• 酵素注射
• 职能治疗
• 其他的
• 全球杜普伊特伦挛缩症市场（依给药途径、绩效与预测），2019-2024 年、2024-2029 年、2034 年
• 口服
• 肠外
• 其他的
• 全球杜普伊特伦挛缩症市场（按诊断、表现和预测），2019-2024 年、2024-2029 年、2034 年
• 身体检查
• X射线
• 其他的
• 全球杜普伊特伦挛缩症市场（按最终用户、绩效和预测），2019-2024 年、2024-2029 年、2034 年
• 医院
• 诊所
• 学术研究所
• 其他的
• 全球杜普伊特伦挛缩症市场：I 型细分（按类型、表现和预测），2019-2024 年、2024-2029 年、2034 年
• 经典杜普伊特伦挛缩症
• 遗传性杜普伊特伦挛缩症
• 全球杜普伊特伦挛缩症市场：II 型细分（按类型、表现和预测），2019-2024 年、2024-2029 年、2034 年
• 掌筋膜炎
• 莱德霍斯病
• 全球杜普伊特伦挛缩症市场：III 型细分（按类型、表现和预测），2019-2024 年、2024-2029 年、2034 年
• 加罗德垫片
• 佩罗尼氏症

第七章 区域和国家分析

• 全球杜普伊特伦挛缩症市场各地区表现及预测（2019-2024、2024-2029、2034）
• 全球杜普伊特伦挛缩症市场（依国家/地区、绩效及预测）2019-2024、2024-2029、2034

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

• 杜普伊特伦挛缩症市场：竞争格局
• 杜普伊特伦挛缩症市场：公司简介
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Aetna Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Mayo clinic Overview, Products and Services, Strategy and Financial Analysis
  • Penn Medicine Overview, Products and Services, Strategy and Financial Analysis
  • Mercy Health Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

• Endo Inc.
• Resilience Orthopedics
• Raleigh Orthopaedic
• Hoag Orthopedic Institute
• OSS Health
• Connext Inc.
• University of Utah Health
• Ventoux Biosciences Inc.
• Auxilium Pharmaceuticals
• 31.11. Brigid Freyne MD
• 31.12. Nantong Jinghua Pharmaceutical Co. Ltd.
• 31.13. Sumitomo Dainippon Pharma Co. Ltd.
• 31.14. Actiza Pharmaceutical Private Limited
• 31.15. Spear Pharmaceuticals

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

• 2029 年杜普伊特伦挛缩症市场：提供新机会的国家
• 2029 年杜普伊特伦挛缩症市场：细分市场带来新机会
• 2029 年杜普伊特伦挛缩症市场：成长策略
  • 基于市场趋势的策略
  • 竞争对手的策略

第36章 附录

Dupuytren's disease, also known as Dupuytren's contracture, is a condition that affects the connective tissue (fascia) in the palm and fingers, leading to thickening and tightening. Over time, this causes the fingers to bend toward the palm, making it difficult to straighten them or perform daily tasks.

The primary types of Dupuytren's disease include Type I, Type II, and Type III. Type I is the most severe form and typically appears in individuals younger than 50. Treatment options include surgery, radiation therapy, needle aponeurotomy, steroid injections, enzyme injections, and occupational therapy, among others. These treatments can be administered through various routes, such as oral or parenteral methods. Diagnosis is conducted through physical examinations, X-rays, and other medical assessments. The condition is managed across various end-users, including hospitals, clinics, academic and research institutions, and other healthcare facilities.

The dupuytren's disease market research report is one of a series of new reports from The Business Research Company that provides dupuytren's disease market statistics, including the dupuytren's disease industry global market size, regional shares, competitors with the dupuytren's disease market share, detailed dupuytren's disease market segments, market trends, and opportunities, and any further data you may need to thrive in the dupuytren's disease industry. This dupuytren's disease market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The dupuytren's disease market size has grown strongly in recent years. It will grow from $4.28 billion in 2024 to $4.55 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth observed in the historical period can be attributed to factors such as a growing aging population, a higher genetic predisposition, an increasing prevalence of diabetes, rising alcohol consumption, and a greater incidence of manual labor and repetitive hand trauma.

The dupuytren's disease market size is expected to see strong growth in the next few years. It will grow to $5.76 billion in 2029 at a compound annual growth rate (CAGR) of 6.0%. The growth expected during the forecast period can be attributed to factors such as advancements in treatment options, greater awareness and earlier diagnosis, rising healthcare spending, increased adoption of minimally invasive procedures, and expanding research and development activities. Key trends during this period include breakthroughs in gene therapy, advancements in regenerative medicine and stem cell therapy, innovations in AI-driven diagnostic tools, progress in 3D printing for custom orthotics, and continued development of minimally invasive surgical techniques.

The increasing popularity of minimally invasive treatments is expected to drive the growth of the Dupuytren's disease market. These treatments are performed with minimal incisions or tissue damage, leading to pain relief and reduced scarring. Patients are increasingly choosing minimally invasive options because they offer quicker recovery, less discomfort, and a lower risk of complications compared to traditional surgery. These treatments effectively help Dupuytren's disease patients by restoring hand function, reducing contractures, and ensuring a faster, more comfortable recovery. For example, a report from the Royal Australasian College of Surgeons (RACS) in June 2023 revealed a 12% increase in procedures performed using da Vinci platforms in Australia, rising from 17,852 in 2021 to 19,989 in 2022. As a result, the growing use of minimally invasive treatments is a key driver of the Dupuytren's disease market expansion.

Leading companies in the Dupuytren's disease market are focusing on clinical trials to develop novel, first-line, disease-modifying treatments. Clinical trials are conducted to assess the safety, effectiveness, and potential side effects of new medical treatments, drugs, or procedures before they are approved for widespread use. In April 2023, Ventoux Biosciences, a US-based biopharmaceutical company focused on developing non-surgical therapies for Dupuytren's disease, announced positive pre-clinical results for its fibrosis treatment targeting Dupuytren's contracture, which affects approximately five percent of the U.S. population. The company's lead candidate, VEN-201, is a repurposed commercially available drug that has shown effectiveness in reducing skin fibrosis in mouse models. This promising outcome led Ventoux to initiate a fundraising round to support the development of VEN-201.

In November 2024, John Elway, a US-based retail company, partnered with Endo Inc. to raise awareness and encourage early diagnosis and treatment of Dupuytren's contracture. The partnership aims to promote XIAFLEX (collagenase clostridium histolyticum) as a non-surgical treatment option for the condition. Endo Inc., a US-based pharmaceutical company, manufactures this medication for Dupuytren's contracture. The collaboration seeks to improve patient outcomes through better awareness and access to treatment options.

Major players in the dupuytren's disease market are Pfizer Inc., Aetna Inc., Mayo clinic, Penn Medicine, Mercy Health, Endo Inc., Resilience Orthopedics, Raleigh Orthopaedic, Hoag Orthopedic Institute, OSS Health, Connext Inc., University of Utah Health, Ventoux Biosciences Inc., Auxilium Pharmaceuticals, 180 Life Sciences Corp., Brigid Freyne MD, Nantong Jinghua Pharmaceutical Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd., Actiza Pharmaceutical Private Limited, Spear Pharmaceuticals.

North America was the largest region in the dupuytren's disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the dupuytren's disease market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The dupuytren's disease market consists of revenues earned by entities by providing services such as diagnosis, physical therapy, minimally invasive treatments, surgical procedures, post-treatment rehabilitation, and related pharmaceutical and medical device solutions. The market value includes the value of related goods sold by the service provider or included within the service offering. The dupuytren's disease market also includes sales of products such as collagenase injections, anti-inflammatory medications, splints, orthopedic braces, surgical instruments, and laser or ultrasound therapy devices used for treatment and management of the condition. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Dupuytren's Disease Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on dupuytren's disease market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for dupuytren's disease ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The dupuytren's disease market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Disease Type: Type I; Type II; Type III
• 2) By Treatment: Surgery; Radiation Therapy; Needle Aponeurotomy; Steroid Shot; Enzyme Injection; Occupational Therapy; Other Treatments
• 3) By Route of Administration: Oral; Parenteral; Other Routes Of Administration
• 4) By Diagnosis: Physical Examination; X-Ray; Other Diagnosis
• 5) By End-User: Hospitals; Clinics; Academic And Research Institute; Other End-Users
• Sub Segments:
• 1) By Type I: Classical Dupuytren's Disease; Familial Dupuytren's Disease
• 2) By Type II: Palmar Fasciitis; Ledderhose Disease
• 3) By Type III: Garrod's Pads; Peyronie's Disease
• Companies Mentioned: Pfizer Inc.; Aetna Inc.; Mayo clinic; Penn Medicine; Mercy Health
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Dupuytren's Disease Market Characteristics

3. Dupuytren's Disease Market Trends And Strategies

4. Dupuytren's Disease Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Dupuytren's Disease Growth Analysis And Strategic Analysis Framework

• 5.1. Global Dupuytren's Disease PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Dupuytren's Disease Market Growth Rate Analysis
• 5.4. Global Dupuytren's Disease Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Dupuytren's Disease Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Dupuytren's Disease Total Addressable Market (TAM)

6. Dupuytren's Disease Market Segmentation

• 6.1. Global Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Type I
• Type II
• Type III
• 6.2. Global Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Surgery
• Radiation Therapy
• Needle Aponeurotomy
• Steroid Shot
• Enzyme Injection
• Occupational Therapy
• Other Treatments
• 6.3. Global Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Parenteral
• Other Routes Of Administration
• 6.4. Global Dupuytren's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Physical Examination
• X-Ray
• Other Diagnosis
• 6.5. Global Dupuytren's Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Academic And Research Institute
• Other End-Users
• 6.6. Global Dupuytren's Disease Market, Sub-Segmentation Of By Type I, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Classical Dupuytren's Disease
• Familial Dupuytren's Disease
• 6.7. Global Dupuytren's Disease Market, Sub-Segmentation Of Type II, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Palmar Fasciitis
• Ledderhose Disease
• 6.8. Global Dupuytren's Disease Market, Sub-Segmentation Of Type III, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Garrod's Pads
• Peyronie's Disease

7. Dupuytren's Disease Market Regional And Country Analysis

• 7.1. Global Dupuytren's Disease Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Dupuytren's Disease Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Dupuytren's Disease Market

• 8.1. Asia-Pacific Dupuytren's Disease Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Dupuytren's Disease Market

• 9.1. China Dupuytren's Disease Market Overview
• 9.2. China Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Dupuytren's Disease Market

• 10.1. India Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Dupuytren's Disease Market

• 11.1. Japan Dupuytren's Disease Market Overview
• 11.2. Japan Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Dupuytren's Disease Market

• 12.1. Australia Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Dupuytren's Disease Market

• 13.1. Indonesia Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Dupuytren's Disease Market

• 14.1. South Korea Dupuytren's Disease Market Overview
• 14.2. South Korea Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Dupuytren's Disease Market

• 15.1. Western Europe Dupuytren's Disease Market Overview
• 15.2. Western Europe Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Dupuytren's Disease Market

• 16.1. UK Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Dupuytren's Disease Market

• 17.1. Germany Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Dupuytren's Disease Market

• 18.1. France Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Dupuytren's Disease Market

• 19.1. Italy Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Dupuytren's Disease Market

• 20.1. Spain Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Dupuytren's Disease Market

• 21.1. Eastern Europe Dupuytren's Disease Market Overview
• 21.2. Eastern Europe Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Dupuytren's Disease Market

• 22.1. Russia Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Dupuytren's Disease Market

• 23.1. North America Dupuytren's Disease Market Overview
• 23.2. North America Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Dupuytren's Disease Market

• 24.1. USA Dupuytren's Disease Market Overview
• 24.2. USA Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Dupuytren's Disease Market

• 25.1. Canada Dupuytren's Disease Market Overview
• 25.2. Canada Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Dupuytren's Disease Market

• 26.1. South America Dupuytren's Disease Market Overview
• 26.2. South America Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Dupuytren's Disease Market

• 27.1. Brazil Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Dupuytren's Disease Market

• 28.1. Middle East Dupuytren's Disease Market Overview
• 28.2. Middle East Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Dupuytren's Disease Market

• 29.1. Africa Dupuytren's Disease Market Overview
• 29.2. Africa Dupuytren's Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Dupuytren's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Dupuytren's Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Dupuytren's Disease Market Competitive Landscape And Company Profiles

• 30.1. Dupuytren's Disease Market Competitive Landscape
• 30.2. Dupuytren's Disease Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Aetna Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Mayo clinic Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Penn Medicine Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Mercy Health Overview, Products and Services, Strategy and Financial Analysis

31. Dupuytren's Disease Market Other Major And Innovative Companies

• 31.1. Endo Inc.
• 31.2. Resilience Orthopedics
• 31.3. Raleigh Orthopaedic
• 31.4. Hoag Orthopedic Institute
• 31.5. OSS Health
• 31.6. Connext Inc.
• 31.7. University of Utah Health
• 31.8. Ventoux Biosciences Inc.
• 31.9. Auxilium Pharmaceuticals
  • 31.10. 180 Life Sciences Corp.
• 31.11. Brigid Freyne MD
• 31.12. Nantong Jinghua Pharmaceutical Co. Ltd.
• 31.13. Sumitomo Dainippon Pharma Co. Ltd.
• 31.14. Actiza Pharmaceutical Private Limited
• 31.15. Spear Pharmaceuticals

32. Global Dupuytren's Disease Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Dupuytren's Disease Market

34. Recent Developments In The Dupuytren's Disease Market

35. Dupuytren's Disease Market High Potential Countries, Segments and Strategies

• 35.1 Dupuytren's Disease Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Dupuytren's Disease Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Dupuytren's Disease Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer